Surgeon Specialization and Use of Sentinel Lymph Node Biopsy for Breast Cancer
Author(s) -
Tina Yen,
Purushuttom W. Laud,
Rodney Sparapani,
Ann B. Nattinger
Publication year - 2013
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2013.4350
Subject(s) - medicine , breast cancer , sentinel lymph node , axillary lymph node dissection , surgery , lymphedema , breast surgery , biopsy , mastectomy , general surgery , population , cancer , axilla , radiology , environmental health
Sentinel lymph node biopsy (SLNB) is the standard of care for axillary staging in patients with clinically node-negative breast cancer. It is not known whether SLNB rates differ by surgeon expertise. If surgeons with less breast cancer expertise are less likely to offer SLNB to these patients, this practice pattern could lead to unnecessary axillary lymph node dissections and lymphedema.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom